Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
305.00    0.00 (0.00%)
Bid:
300.00
Ask:
310.00
Spread: 10.00 (3.333%)
Market Cap: £38.70m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Trading Update

20 Jan 2026 07:00

RNS Number : 5104P
System1 Group PLC
20 January 2026
 

 

 

 

 

20 January 2026

 

System1 Group PLC (AIM: SYS1)

 ("System1", or "the Company", or "the Group")

Trading Update - Growth in Platform Revenue in Q3 over first two quarters-

FY26 guidance maintained

 

System1 www.system1group.com today issues an update on trading for the quarter ended 31 December 2025 ("Q3 FY26", "Q3").

 

Platform revenue in Q3 was higher than the preceding two quarters, benefiting from increased Adtesting revenue in the UK and Europe which in H1 experienced reduced, but ongoing, spend by many clients due to the wider macroeconomic uncertainty.

 

Platform revenue was in line with the previous record Q3 FY25, and grew by 1% against that Q3 FY25 in constant currency. US platform revenue was in line with H1, and momentum in Innovation Platform revenue continued.

 

Non-platform revenue was £0.4m lower than in Q3 FY25 resulting in a 4% fall in reported total Group revenue (3% at constant currency) compared with last year's record Q3.

 

Revenue from new client wins grew by 10% in the first nine months of FY26 compared with the same period in FY25. These new clients contributed £7.4m of the £25.7m Platform Revenue in the year to date, a third of it in the US, and provide significant opportunities for future growth.

 

The Group held net cash of £8.3m at the end of December (Dec 2024: £10.2m) following the £1.4m dividend payment in October.

 

The Board maintains the FY26 guidance1 it provided on 23 September 2025 and in the interim results on 2 December 2025.

 

 

 

 

Revenue £ million - unaudited

Q3

Q3

Q3

YTD

YTD

YTD

FY26

FY25

% YoY

FY26

FY25

% YoY

Predict Your (data)

8.1

8.2

-1%

21.5

21.5

0%

Improve Your (data-led consultancy)

1.4

1.3

8%

4.2

4.7

-11%

Platform Revenue

9.5

9.5

0%

25.7

26.2

-2%

Other consultancy (non-platform)

0.3

0.7

-57%

1.2

2.3

-48%

Total Revenue

9.8

10.2

-4%

26.9

28.5

-6%

 

Commenting on the trading update, CEO James Gregory said: "Q3 saw a recovery in our revenue, particularly in UK & Europe, with many of our largest clients' Adtesting spend normalising after a reduced H1, providing some momentum for Q4. We therefore remain confident in maintaining our guidance for the year."

 

Further information on the Company can be found at www.system1group.com.

 

1 For the purpose of this announcement, the guidance provided in the 23 September 2025 announcement was for FY26 Revenue to be broadly in line with the £37m achieved in FY25, and Adjusted Profit beforeTaxation2 in a range between £2.0 to £2.5 million.

2 Adjusted Profit is Profit before Taxation excluding share-based payments

 

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. With the publication of this announcement, this information is now considered to be in the public domain.

 

For further information, please contact:

System1 Group PLC

Tel: +44 (0)7467 990147

James Gregory, Chief Executive Officer

Chris Willford, Chief Financial Officer

 

Canaccord Genuity Limited (Nominated Adviser & Broker)

 

Tel: +44 (0)20 7523 8000

Simon Bridges / Andrew Potts / Harry Rees

 

Singer Capital Markets (Joint Broker)

Tel: +44 (0) 20 7496 3000 

James Moat / James Fischer / Sara Hale

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUKSRRNKUAAUR
Date   Source Headline
12th Sep 20172:31 pmRNSHolding(s) in Company
21st Aug 20175:49 pmRNSHolding(s) in Company
21st Aug 20177:00 amRNSResult of AGM
18th Aug 20177:00 amRNSTrading Update
11th Jul 20171:18 pmRNSAnnual Report and Notice of AGM
3rd Jul 20177:59 amRNSTotal Voting Rights
26th Jun 201711:23 amRNSDirector/PDMR Shareholding
16th Jun 20171:33 pmRNSExercise of Options and Director Dealing
15th Jun 20177:00 amRNSDividend Declaration
15th Jun 20177:00 amRNSDirectorate Change
15th Jun 20177:00 amRNSFinancial results to 31 March 2017
11th May 20175:47 pmRNSHolding(s) in Company
19th Apr 20177:00 amRNSTrading Update
3rd Apr 20177:00 amRNSChange of Name
24th Mar 20177:00 amRNSChange of Name
22nd Mar 20174:31 pmRNSGrant of Options
22nd Mar 20173:44 pmRNSResult of General Meeting
1st Mar 20172:02 pmRNSTotal Voting Rights
28th Feb 20172:58 pmRNSDirector/PDMR Shareholding
24th Feb 20177:00 amRNSNotice of GM
10th Feb 20173:46 pmRNSExercise of Options
9th Feb 20177:00 amRNSResults for the 12 months ended 31 December 2016
7th Feb 20177:00 amRNSBoard Appointment
20th Jan 20177:00 amRNSTrading Update
9th Dec 20167:00 amRNSTrading Update
1st Dec 201612:45 pmRNSTotal Voting Rights
1st Nov 20165:34 pmRNSTransaction in Own Shares
1st Nov 20161:35 pmRNSTotal Voting Rights
13th Oct 20165:34 pmRNSTransaction in Own Shares
12th Oct 20161:44 pmRNSTransaction in Own Shares
4th Oct 20167:00 amRNSDirectorPDMR Dealing and Transaction in Own Shares
30th Sep 20165:15 pmRNSTransaction in Own Shares
27th Sep 20164:57 pmRNSExercise of Options, PDMR Shareholding
22nd Sep 20167:00 amRNSExercise of Options and Transaction in Own Shares
22nd Sep 20167:00 amRNSTransaction in Own Shares
20th Sep 20166:23 pmRNSHolding(s) in Company
19th Sep 20167:00 amRNSTransaction in Own Shares
16th Sep 20167:00 amRNSInterim Results
16th Sep 20167:00 amRNSDividends and Share Buyback
9th Sep 20164:39 pmRNSHolding(s) in Company
9th Sep 20161:20 pmRNSHolding(s) in Company
26th Aug 201611:42 amRNSHolding(s) in Company
16th Aug 20164:15 pmRNSAdditional Listing
15th Jul 20167:00 amRNSTrading Update
20th Jun 20164:40 pmRNSTransaction in Own Shares
6th Jun 20164:45 pmRNSDirector Dealing
6th Jun 201611:17 amRNSDirector Dealing
3rd Jun 20162:17 pmRNSHolding(s) in Company
2nd Jun 20166:02 pmRNSDirector Dealing and Transaction in Own Shares
18th May 20165:46 pmRNSDirector Dealing and Transaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.